Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients

NCT02235519 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hypertension
Obesity
Type 2 Diabetes Mellitus

Interventions

DRUG: Azilsartan 40 mg.
DRUG: Azilsartan 80 mg

Sponsor

Hospital General de México Dr. Eduardo Liceaga